Solventum Corporation SOLV | NYSE

$73.57 $0.94 | 1.29%

After Hours
$74.22 $0.65 | 0.88%

Next Earnings: Aug 04, 2025

Company Overview:

Market Cap: $12.73B
PE Ratio: 33.9
52-Week Range: $47.16 - $85.92

1.2 Year SOLV Performance Metrics:

Total Return (with DRIP): 6.5% (5.36% CAGR)
Total Return (no DRIP): 6.5% (5.36% CAGR)
Share Price: 6.5% (5.36% CAGR)
SOLV Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

SOLV Earnings, Revenue, Cash & Debt, Shares Outstaning:

SOLV - Revenue
14-Day FREE Trial Get Full Access Now!
SOLV Revenue CAGR:1Y: 2.68%2Y: 0.65%5Y: 0.00%10Y: 0.00%
SOLV - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
SOLV EPS CAGR:1Y: -43.07%2Y: -33.80%5Y: 0.00%10Y: 0.00%
SOLV - Net Income
14-Day FREE Trial Get Full Access Now!
SOLV Net Income CAGR:1Y: -42.19%2Y: -31.62%5Y: 0.00%10Y: 0.00%
SOLV - EBITDA
14-Day FREE Trial Get Full Access Now!
SOLV EBITDA CAGR:1Y: -70.77%2Y: -47.41%5Y: 0.00%10Y: 0.00%
SOLV - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
SOLV Free Cash Flow CAGR:1Y: -123.53%2Y: N/A5Y: 0.00%10Y: 0.00%
SOLV - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
SOLV Free Cash Flow / Share CAGR:1Y: -123.39%2Y: N/A5Y: 0.00%10Y: 0.00%
SOLV - Operating Income
14-Day FREE Trial Get Full Access Now!
SOLV Operating Income CAGR:1Y: -60.21%2Y: -39.15%5Y: 0.00%10Y: 0.00%
SOLV - Gross Profit
14-Day FREE Trial Get Full Access Now!
SOLV Gross Profit CAGR:1Y: -5.03%2Y: -2.13%5Y: 0.00%10Y: 0.00%
SOLV - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
SOLV Shares Outstanding CAGR:1Y: 1.22%2Y: 0.67%5Y: 0.00%10Y: 0.00%
SOLV - Share Buybacks
14-Day FREE Trial Get Full Access Now!
SOLV Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
SOLV - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
SOLV Stock-Based Comp CAGR:1Y: 1,125.00%2Y: 64.99%5Y: 0.00%10Y: 0.00%
SOLV - Expenses
14-Day FREE Trial Get Full Access Now!
SOLV Expenses CAGR:1Y: 6.86%2Y: 29.50%5Y: 0.00%10Y: 0.00%
SOLV - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
SOLV - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
SOLV - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
SOLV - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
SOLV - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
SOLV - Cash & Debt
14-Day FREE Trial Get Full Access Now!
SOLV - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
SOLV Revenue CAGR:1Y: 2.68%2Y: 0.65%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

SOLV - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
SOLV Actual Revenue CAGR:1Y: 2.68%2Y: 0.65%5Y: 0.00%10Y: 0.00%
SOLV - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
SOLV Actual EPS CAGR:1Y: -43.07%2Y: -33.80%5Y: 0.00%10Y: 0.00%
SOLV - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
SOLV Actual Net Income CAGR:1Y: -42.19%2Y: -31.62%5Y: 0.00%10Y: 0.00%
SOLV - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
SOLV Actual EBITDA CAGR:1Y: -70.77%2Y: -47.41%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

SOLV - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
SOLV Net Profit Margin CAGR:1Y: -43.71%2Y: -32.06%5Y: 0.00%10Y: 0.00%
SOLV - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
SOLV Gross Profit Margin CAGR:1Y: -7.49%2Y: -2.75%5Y: 0.00%10Y: 0.00%
SOLV - Price to Earnings
14-Day FREE Trial Get Full Access Now!
SOLV - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
SOLV - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
SOLV - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for SOLV

Based on past 1.2-year performance, here are SOLV growth metrics:

Share price CAGR of +5.36%
Dividend CAGR of +0%

Using SOLV CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

SOLV (DRIP)SOLV - No DRIP
Current Price$73.57$73.57
Start Shares135.92135.92
Start Value$10,000$10,000
  
After 10 years:
Final Share Count135.92135.92
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$117.73$73.57
Total Dividends$0$0
Final Value$16,002$10,000

Estimated Future Value + Dividends - SOLV

NOTE: Above numbers are our estimate based on SOLV's Dividend and Price CAGR over past 1.2 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Solventum Corporation (SOLV) had its IPO on 2024-04-01, and is trader on NYSE stock exchange.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

SOLV website: https://www.solventum.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$35/mo
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 20% OFF
$336/yr
7-days Free Trial
YMTracker & Earnings / Dividends / Estimate Reports for 1000s of Stocks
YMTracker
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial